EUVIMEDOpdag EUVIMED
Open access

Early success of the COCOON trial: Preventing dermatologic adverse events in first-line EGFR-mutant NSCLC

Bishal Tiwari, Asmita Koirala

Oncoscience · 2026-03-11 · 13 · 69-76

DOI: 10.18632/oncoscience.648 ↗

At a glance

Journal article in Oncoscience, published on 2026-03-11. Written by Bishal Tiwari and 1 co-authors. Institution: Nassau University Medical Center, East Meadow, NY 11554, USA. 11 references. The full text is freely available in PubMed Central.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Intet abstract tilgængeligt.

Subjects

Author keywords

COCOON trialEGFR-mutant non-small cell lung canceramivantamabdermatologic adverse eventslazertinib

Authors and institutions

  • Nassau University Medical Center, East Meadow, NY 11554, USA.
  • Western Regional Hospital, Pokhara, Nepal.

Cite

APA

Tiwari, B., & Koirala, A. (2026). Early success of the COCOON trial: Preventing dermatologic adverse events in first-line EGFR-mutant NSCLC. Oncoscience, 13, 69-76. https://doi.org/10.18632/oncoscience.648

Vancouver

Tiwari B, Koirala A. Early success of the COCOON trial: Preventing dermatologic adverse events in first-line EGFR-mutant NSCLC. Oncoscience. 2026;13:69-76. doi:10.18632/oncoscience.648

BibTeX
@article{Tiwari2026,
  author = {Tiwari, Bishal and Koirala, Asmita},
  title = {Early success of the COCOON trial: Preventing dermatologic adverse events in first-line EGFR-mutant NSCLC},
  journal = {Oncoscience},
  year = {2026},
  volume = {13},
  pages = {69--76},
  doi = {10.18632/oncoscience.648}
}
Start for free →